ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2010;89:125-131. doi:10.1016/j.athoracsur.2009.09.007
© 2010 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Discussion (Adult)
Right arrow Online Discussion (Pediatric)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Leopold Rupprecht
Daniele Camboni
Frank Bruenger
Michael Hilker
Christof Schmid
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floerchinger, B.
Right arrow Articles by Schmid, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floerchinger, B.
Right arrow Articles by Schmid, C.
Related Collections
Right arrow Extracorporeal circulation
Right arrowRelated Article


Original Articles: Adult Cardiac

Switch From Venoarterial Extracorporeal Membrane Oxygenation to Arteriovenous Pumpless Extracorporeal Lung Assist

Bernhard Floerchinger, MDa, Alois Philipp, ECCPa, Maik Foltan, ECCPa, Leopold Rupprecht, MDa, Alexander Klose, MDa, Daniele Camboni, MDa, Frank Bruenger, MDa, Simon Schopka, MDa, Mathias Arlt, MDb, Michael Hilker, MDa, Christof Schmid, MDa,*

a Department of Cardiothoracic Surgery, University Hospital of Regensburg, Regensburg, Germany
b Department of Anesthesiology, University Hospital of Regensburg, Regensburg, Germany

Accepted for publication September 1, 2009.

* Address correspondence to Dr Schmid, Department of Cardiothoracic Surgery, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany (Email: christof.schmid{at}klinik.uni-regensburg.de).

Background: Extracorporeal membrane oxygenation is an effective rescue tool to treat cardiopulmonary failure. Pumpless systems treat lung failure only; they require adequate cardiac output.

Methods: We report on 18 patients initially provided with venoarterial extracorporeal membrane oxygenation and then downgraded to a pumpless arteriovenous shunt with a membrane oxygenator by removal of the pump from the circuit after hemodynamic stabilization in the face of persisting pulmonary failure. Main underlying diseases were adult respiratory distress syndrome (44%) and pneumonia (28%). Mean patient age was 44 years, and mean body mass index was 25.7 kg/m2. Anticoagulation, hemodynamic, and respiratory variables were analyzed.

Results: All patients exhibited severe cardiopulmonary failure with a mean oxygenation ratio (partial pressure of oxygen to fraction of inspired oxygen ratio) of 74 ± 43 mm Hg (mean partial pressure of oxygen, 70 ± 33 mm Hg) and a mean partial pressure of carbon dioxide of 68 ± 32 mm Hg despite maximal (ventilatory) conservative therapy (fraction of inspired oxygen, 0.98 ± 0.08). Initial serum lactate was 51 ± 43 mg/dL. The sequential organ failure assessment score averaged 11.8 ± 2.47, and the lung injury score was 3.1 ± 0.58. Total mechanical respiratory support was performed for a mean of 13.6 ± 15.7 days. After 24 hours an improvement in oxygenation and a decrease in carbon dioxide was achieved with a mean partial pressure of carbon dioxide of 40 ± 11 mm Hg (p < 0.001) and a partial pressure of oxygen of 86 ± 26 mm Hg (p = 0.031). After 6 ± 3 days of extracorporeal membrane oxygenation, patients were hemodynamically stabilized. Extracorporeal membrane oxygenation was downgraded to pumpless extracorporeal lung assist for another 10 ± 15 days (range, 2 to 71 days). Twelve patients (66.7%) could be weaned, with a 30-day mortality of 55.6%. Norepinephrine dosage could be reduced significantly within 24 hours (3.2 ± 1.8 versus 1.5 ± 1.5 mg/h; p = 0.008).

Conclusions: Respiratory support by an extracorporeal device used as last resort therapy allows rapid stabilization of patients with acute lung failure. Early replacement of extracorporeal membrane oxygenation by pumpless extracorporeal lung assist minimizes the negative side effects of extracorporeal circulation.


Related Article

Invited Commentary
James E. Lynch and Joseph B. Zwischenberger
Ann. Thorac. Surg. 2010 89: 131. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. Haneya, A. Philipp, T. Mueller, M. Lubnow, M. Pfeifer, W. Zink, M. Hilker, C. Schmid, and S. Hirt
Extracorporeal Circulatory Systems as a Bridge to Lung Transplantation at Remote Transplant Centers
Ann. Thorac. Surg., January 1, 2011; 91(1): 250 - 255.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. E. Lynch and J. B. Zwischenberger
Invited Commentary
Ann. Thorac. Surg., January 1, 2010; 89(1): 131 - 131.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2010 by The Society of Thoracic Surgeons.